Renal protection in chronic heart failure: focus on sacubitril/valsartan

R Pontremoli, C Borghi… - European Heart Journal …, 2021 - academic.oup.com
Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF)
and increases the risk of overall and cardiovascular (CV) mortality. Despite evidence …
被引用次数：37 相关文章

Renal protection in chronic heart failure: focus on sacubitril/valsartan

R Pontremoli, C Borghi, PP Filardi - European Heart Journal …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Chronic kidney disease (CKD) is highly
prevalent in patients with chronic heart failure (CHF) and increases the risk of overall and …

Renal protection in chronic heart failure: focus on sacubitril/valsartan

R Pontremoli, C Borghi… - European Heart Journal …, 2021 - search.proquest.com
Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF)
and increases the risk of overall and cardiovascular (CV) mortality. Despite evidence …
[PDF] semanticscholar.org

[PDF][PDF] Renal protection in chronic heart failure: focus on sacubitril/valsartan

R Pontremoli, C Borghi, PP Filardi - pdfs.semanticscholar.org
Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF)
and imposes a considerable unfavourable prognostic burden in terms of global and …

Renal protection in chronic heart failure: focus on sacubitril/valsartan

R Pontremoli, C Borghi, PP Filardi - EUROPEAN HEART JOURNAL …, 2021 - cris.unibo.it
Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF)
and increases the risk of overall and cardiovascular (CV) mortality. Despite evidence …

Renal protection in chronic heart failure: focus on sacubitril/valsartan.

R Pontremoli, C Borghi - European Heart journal. Cardiovascular …, 2021 - europepmc.org
Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF)
and increases the risk of overall and cardiovascular (CV) mortality. Despite evidence …
[HTML] nih.gov

[HTML][HTML] Renal protection in chronic heart failure: focus on sacubitril/valsartan

R Pontremoli, C Borghi, PP Filardi - European Heart Journal …, 2021 - ncbi.nlm.nih.gov
Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF)
and increases the risk of overall and cardiovascular (CV) mortality. Despite evidence …

Renal protection in chronic heart failure: focus on sacubitril/valsartan

R Pontremoli, C Borghi… - European heart journal …, 2021 - pubmed.ncbi.nlm.nih.gov
Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF)
and increases the risk of overall and cardiovascular (CV) mortality. Despite evidence …

Renal protection in chronic heart failure: Focus on sacubitril/valsartan

R Pontremoli, C Borghi, P Perrone Filardi - EUROPEAN HEART …, 2021 - iris.unina.it
Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF)
and increases the risk of overall and cardiovascular (CV) mortality. Despite evidence …
[PDF] oup.com

[PDF][PDF] Renal protection in chronic heart failure: focus on sacubitril/valsartan

R Pontremoli, C Borghi… - European Heart Journal …, 2021 - academic.oup.com
Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF)
and increases the risk of overall and cardiovascular (CV) mortality. Despite evidence …